A practical reference on lyophilised powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-22 and is reviewed periodically as new material appears.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (dry) | -20 °C | Protected from light and moisture |
| Storage temperature (solution) | -80 °C | Single-use aliquots recommended |
| Identity assay | LC-MS or MALDI-TOF | Confirms mass near 889 Da |
| Purity assay | RP-HPLC | Reports main peak percentage |
| Common impurities | Truncated peptides, deamidated forms | Arise from synthesis or storage |
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
== Replication == Replication of the R1 plasmid begins at the oriRI site on the plasmid. RepA is the plasma-encoded initiator protein that binds to oriRI in order to initiate replication. RepA needs a 188-bp region of DNA at minimum in order to bind. Initiation of the leading strand, primed by DnaG, occurs at a G-type priming signal. This signal is located 400 bp downstream of the RepA-binding sequences. A newly synthesized RepA protein is used by an oriR on the same template that it was synthesized on, a cis-specific action.
The loss of function (functio laesa) is probably the result of a neurological reflex in response to pain. In addition to cell-derived mediators, several acellular biochemical cascade systems—consisting of preformed plasma proteins—act in parallel to initiate and propagate the inflammatory response. These include the complement system activated by bacteria and the coagulation and fibrinolysis systems activated by necrosis (e.g., burn, trauma). Acute inflammation may be regarded as the first line of defense against injury. Acute inflammatory response requires constant stimulation to be sustained. Inflammatory mediators are short-lived and are quickly degraded in the tissue. Hence, acute inflammation begins to cease once the stimulus has been removed.
=== Home media === The film was released by The Criterion Collection as a Region 1 DVD on 25 November 2008 and on Blu-ray on 10 September 2013. Extras for this version include: digitally restored picture and sound; an interview with John le Carré; scene-specific commentary by director of photography Oswald Morris; a BBC documentary titled The Secret Centre: John le Carré (2000); an interview with Richard Burton from a 1967 episode of the BBC series Acting in the '60s; a 1985 audio interview with director Martin Ritt; a gallery of set designs; the film's theatrical trailer; and a booklet featuring an essay by film critic Michael Sragow.
=== Germany === In 2005, a product called Subyou was reportedly distributed from Germany on the Internet. The product was available in four flavors and packed in 65-gram, or possibly 100-gram, sachets. When mixed with 0.25 liters of water, it created a drink with 4.8% alcohol. It was assumed that a German producer manufactured the alcopop powder based on imported raw alcohol powder from the U.S. Later, Subyou disappeared and its website 'subyou.de' was taken down.
Sources: en.wikipedia.org
By the mid-2000s, Liebling had nearly disappeared from public life. He spent his days isolated in his parents' basement, trapped in a relentless cycle of addiction and self-destructive behavior. The toll of decades of substance abuse was evident in his skeletal frame, which was covered in sores and barely functioning, leading many to believe he was beyond redemption. This chapter of his life, which took an unexpected turn, became the subject of the documentary Last Days Here (2011), directed by Don Argott and Demian Fenton. Filmed over four years, the documentary follows Liebling, who is in his 50s and living in the basement of his parents' house in Alexandria, Virginia, as he battles severe drug addiction. His friend, manager, and longtime Pentagram fan Sean "Pellet" Pelletier took it upon himself to pull Liebling out of the abyss and get him back to music and a healthier life. Alongside Pelletier, the film features interviews with former Pentagram members, friends, Liebling's parents, and his then-girlfriend, Hallie. The documentary ends on a hopeful note; by 2010, Pentagram had returned to the stage, and Liebling was sober, married to Hallie, and expecting their first child. When Argott and Fenton first met Liebling, they had little hope that his story would lead anywhere. "Bobby was in such bad shape when Pellet introduced us to him that we didn't think his story would go anywhere. It really seemed like he was going to smoke himself to death in his parents' basement, something we weren't interested in documenting," Fenton recalled.
Vitexin is an apigenin flavone glucoside, a chemical compound found in the passion flower, Vitex agnus-castus (chaste tree or chasteberry), in the Phyllostachys nigra bamboo leaves, in the pearl millet (Pennisetum millet), and in hawthorn.
In electrochemistry, cyclic voltammetry (CV) is a type of voltammetric measurement where the potential of the working electrode is ramped linearly versus time. Unlike in linear sweep voltammetry, after the set potential is reached in a CV experiment, the working electrode's potential is ramped in the opposite direction to return to the initial potential. These cycles in potential are repeated until the voltammetric trace reaches a cyclic steady state. The current at the working electrode is plotted versus the voltage at the working electrode to yield the cyclic voltammogram (see Figure 1). Cyclic voltammetry is generally used to study the electrochemical properties of an analyte in solution or of a molecule that is adsorbed onto the electrode and to quantify electrochemical surface area of catalysts in electrochemical cells.
Sources: en.wikipedia.org
== Bicun == Bicun is Simcere Pharmaceutical's prescription edaravone injection pharmaceutical for the treatment of strokes. Edaravone is a synthetic-free radical scavenger and has been proved to be effective. Edaravone protects the brain by eliminating excessive free radicals, which are highly reactive molecules occurring in the human body as a result of stroke, an excessive number of which could result in cell damage.
The researchers have set out to answer possible questions from teachers using the program, highlight some minimum recommended training requirements for the software, suggest some "hints and tips" for teaching ideas, explain the importance of performing more studies / trials with the program, overview randomised controlled trial usage of the software, and highlight the importance of obtaining feedback from lesson participants. The recommendations seem to be straightforward and should help in formalising training with the program, as well as in the development of a network of teachers "accredited" to give lessons using the software.
The Don Cossacks were revived in the early 1990s and were officially recognised by the Russian Government in 1997, its Ataman holding the rank, insignia and uniform of a full Marshal. In 1992 they joined the separatist forces during the Transnistria War. Don Cossacks volunteered by hundreds to fight in South Ossetia during the 2008 Russo-Georgian war. In 2009, the Ukrainian Security Service banned a leader of the Don Cossacks from entering Ukraine in order to prevent the creation of an illegal parliamentary formation on Ukrainian territory. Since 2014, members of Don Cossacks have participated in the war in Eastern Ukraine as independent volunteers for the pro-Russian Donbass militias. Reportedly several military formations were formed though most of these groups were subsequently disbanded and integrated into the armed forces of the DPR and LPR.
The first organic cofactor to be discovered was NAD+, which was identified by Arthur Harden and William Young 1906. They noticed that adding boiled and filtered yeast extract greatly accelerated alcoholic fermentation in unboiled yeast extracts. They called the unidentified factor responsible for this effect a coferment. Through a long and difficult purification from yeast extracts, this heat-stable factor was identified as a nucleotide sugar phosphate by Hans von Euler-Chelpin. Other cofactors were identified throughout the early 20th century, with ATP being isolated in 1929 by Karl Lohmann, and coenzyme A being discovered in 1945 by Fritz Albert Lipmann. The functions of these molecules were at first mysterious, but, in 1936, Otto Heinrich Warburg identified the function of NAD+ in hydride transfer. This discovery was followed in the early 1940s by the work of Herman Kalckar, who established the link between the oxidation of sugars and the generation of ATP. This confirmed the central role of ATP in energy transfer that had been proposed by Fritz Albert Lipmann in 1941. Later, in 1949, Morris Friedkin and Albert L. Lehninger proved that NAD+ linked metabolic pathways such as the citric acid cycle and the synthesis of ATP.
Sources: en.wikipedia.org
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.
Reverse-phase HPLC assesses purity, and mass spectrometry confirms molecular mass. The combination helps distinguish the target peptide from truncated or modified impurities.
Buffer composition, pH, adsorption to containers, and freeze-thaw history can all affect the amount of intact peptide in solution. These factors may change results even when the starting material is chemically correct.
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.